INTRODUCTION
The hydrolysis of arachidonic acid (AA) and other unsaturated fatty acids from the sn-2 position of membrane phospholipids initiates a cascade of metabolic events which mediate both intracellular signal transduction and intercellular communication [1] . Thus, AA is a precursor for a family of oxygenated metabolites synthesized via the cyclo-oxygenase (prostanoids) and lipoxygenase (leukotrienes) pathways [2] . These bioactive eicosanoids exert pleiotropic effects on cellular functions which implicate them as important mediators of both normal homoeostasis and pathophysiological states. Alternatively, free unsaturated fatty acids can themselves function as second messengers, directly modulating such processes as release of intracellular Ca# + [3] , activation of protein kinase C [4] and mitogenactivated protein kinases [5] , generation of superoxide anion [6] , polypeptide synthesis [7] , and transcription of heat shock genes [8] . Finally, the other products of phospholipid hydrolysis, namely lysophospholipids, can themselves be metabolized to platelet-activating factor as well as modulate the transduction of cellular signals [9] .
The key enzyme responsible for sn-2 deacylation is phospholipase A # (PLA # ). A substantial body of work carried out in recent years has identified at least five separate PLA # isoforms, each being a distinct gene product with its own distinct biochemical characteristics [10, 11] . Of these, cytosolic or cPLA # is one isoform which has been suggested to be a good candidate to Abbreviations used : AA, arachidonic acid ; PLA 2 , phospholipase A 2 ; cPLA 2 , cytosolic PLA 2 ; AEC, alveolar epithelial cell ; DMEM, Dulbecco's modified Eagle's medium ; ETYA, eicosatetraynoic acid ; BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,Nh,Nh-tetra-acetic acid ; AACOCF 3 , arachidonyl trifluoromethyl ketone ; ICAM-1, intracellular adhesion molecule-1 ; COX-1, cyclo-oxygenase-1.
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fluorescence microscopic analysis as well as subcellular fractionation with immunoblotting, ionophore treatment resulted in a translocation of cPLA # protein from the cytoplasm to the nuclear envelope. To determine whether the nuclear membrane was indeed the source of released AA, prelabelled cells were incubated in the presence or absence of A23187, after which the phospholipid radioactivity was quantified in nuclear and nonnuclear membrane fractions. [$H]AA was distributed in both nuclear and non-nuclear membrane phospholipids. Following A23187 stimulation, the loss of [$H]AA from nuclear membrane phospholipids accounted for 88.1p5.8 % of the total loss from phospholipids and for 92.9p2.3 % of the total [$H]AA released into the medium. These results demonstrate for the first time that agonist-stimulated translocation of cPLA # to the nuclear envelope is associated with phospholipid hydrolysis which is preferentially localized to that site. mediate agonist-stimulated phospholipid hydrolysis because of (i) its preference for AA over other fatty acids, (ii) its activity at physiological (nM) intracellular Ca# + concentrations, and (iii) its phosphorylation-dependent regulation by hormonal and other relevant stimuli. As its name implies, this 85 kDa protein is located in the cytosol of resting cells, but undergoes a Ca# + -dependent translocation to a membrane site following cell activation [12] . This site was initially assumed to be the plasma membrane ; however, recent studies employing immunofluorescence microscopic analysis [13] and subcellular fractionation\ immunoblot analysis [14] in rat basophilic leukaemia cells and peritoneal macrophages, respectively, have instead demonstrated it to be the nuclear envelope. As surprising as this finding was, it remains to be established whether this translocation event is associated with functional evidence of phospholipid hydrolysis at the nuclear envelope. The present study was undertaken to address precisely this question.
Herein, we have utilized primary cultures of rat type-II alveolar epithelial cells (AECs), or pneumocytes. These cells line the alveolar surface of the lung, and therefore comprise the immense interface between the lung and the inspired air. They are capable of releasing AA and metabolizing it to large quantities of prostaglandins and to lesser amounts of hydroxyeicosatetraenoic acids [15] . We have previously reported that AECs contain cPLA # as well as a Ca# + -independent PLA # activity [16] . Our results demonstrate that the model agonist, ionophore A23187, promotes AA release in AECs via a cPLA # -mediated mechanism, that it causes translocation of cPLA # protein from the cytosol to the nuclear envelope, and that it causes phospholipid hydrolysis primarily at the nuclear membrane.
EXPERIMENTAL Materials
Male specific pathogen-free Sprague-Dawley rats (180-200 g) were obtained from Charles River. Dulbecco's modified Eagle's medium (DMEM) and fetal-calf serum were obtained from Gibco. [5,6,8,9,11,12,14,15- 
Cell isolation and culture
Rat type-II AECs were isolated by standard techniques [17] and cultured in DMEM containing 10 % (v\v) fetal-calf serum (serum-containing medium). They were studied at culture day 7 because it is at this time that AA release is maximal [18] , reflecting increased expression of cPLA # protein and activity as compared with earlier time points [19] . AEC purity, assessed by cytokeratin staining, was " 95 % [18] . For AA release studies, 0.5i10' AECs were cultured in 1 ml in each well of a 24-well plate ; for phospholipid analysis of subcellular fractions, 10( cells were cultured in 10 ml in a 100-mm-diam. dish.
Prelabelling of cellular lipids
AEC lipids were prelabelled to equilibrium by adding 0.3 µCi of [$H]AA or [$H]oleic acid per ml of serum-containing medium [19] at day 6 in culture. After a 24 h labelling interval, the labelling medium was removed, cells were washed three times with Ca# + -and Mg# + -free PBS, and cellular uptake of radiolabel was determined by scraping cells in methanol and scintillation counting. Incorporation was routinely " 60 % of added radioactivity for AA and " 50 % for oleic acid.
Determination of fatty acid release in intact cells
[$H]Fatty acid release was ordinarily determined by stimulating prelabelled cells in DMEM containing 0.1 % BSA [19] and counting total radioactivity in the medium. BSA serves to trap all the released fatty acid, thereby preventing its re-acylation back into phospholipids as well as its metabolism to eicosanoids. Under these conditions, radioactivity measured in the medium reflects only deacylation. In experiments testing the effects of AACOCF $ , stimulation was performed in the absence of BSA and free [$H]AA levels were instead determined by extracting lipids from cells plus medium and separating neutral lipids by TLC [19] . The spots on the chromatogram which correspond to free fatty acid were then cut out and subjected to scintillation counting. In all instances, radioactivity was expressed as a percentage of the radiolabel incorporated into cells.
Experimental incubations
Cells were stimulated for 60 min in serum-free DMEM alone (with or without BSA) or in the same medium containing 5 µM A23187. The effects of the intracellular Ca# + chelator BAPTA were examined by preloading cells with the cell-permeant acetoxymethyl ester derivative BAPTA\AM for 60 min prior to stimulation. A 2-min preincubation with the inhibitor AACOCF $ was preceded by a 10-min pretreatment with 10 µM ETYA to inhibit re-acylation [20] ; A23187 was then added.
Indirect immunofluorescence microscopy
AECs were plated on sterilized glass coverslips placed into 4-well plates and cultured as described above. At culture day 7, serumcontaining medium was removed, cells were washed twice with PBS, and incubated with DMEM in the absence or presence of A23187 at 37 mC for 30 min. After agonist stimulation, they were fixed in methanol at k20 mC for 30 min, permeabilized in acetone at k20 mC, and air-dried. They were then rehydrated with PBS-3 % BSA for 5 min at room temperature, and blocked by the addition of 10 % non-immune goat serum for 30 min. Cells were incubated for 1 h at 37 mC with anti-cPLA # IgG at a titre of 1 : 20 or with an identical amount of normal rabbit IgG. They were then washed six times with PBS-3 % BSA and incubated for 30 min at 37 mC with a 1 : 200 titre of rhodamine-conjugated goat anti-rabbit IgG. The coverslip was mounted on a slide and fluorescence visualized with a Nikon Labophot 2 microscope equipped for epifluorescence.
Subcellular fractionation and immunoblot analysis
AECs were washed twice with ice-cold PBS containing 1 mM EGTA, detached by incubation at 37 mC for 5 min with 1 ml of 0.25 % trypsin, and immediately diluted into medium. They were then pelleted, washed once with medium, and resuspended in medium at 2i10' cells\ml. Cells were treated for 30 min with an equal volume of medium alone or medium containing A23187 (final concentration, 5 µM), washed with PBS, and resuspended at 10( cells\ml in ice-cold TKM buffer (50 mM Tris\HCl, pH 7.4, 25 mM KCl, 5 mM MgCl # , 1 mM EGTA) containing 1 mM each of PMSF, leupeptin, NaF, and sodium orthovanadate, as described [21] . They were permitted to swell by incubation on ice for 10 min, and were then disrupted by dounce homogenization. The relative numbers of unbroken cells and intact nuclei were determined by microscopic examination of cytospin preparations of these suspensions which had been mixed with Trypan Blue. On the basis of preliminary experiments, a protocol employing 250 strokes was selected because it consistently resulted in a minimal number of unbroken cells ( 2 %) along with minimal disruption of the nuclear membrane ; fewer strokes yielded more unbroken cells, and more strokes yielded fewer intact nuclei. For subcellular fractionation, 0.6 ml of 0.25 M sucrose-TKM was added to the homogenate and this was centrifuged at 1000 g for 5 min. This low-speed pellet was designated the ' nuclear ' fraction. The low-speed supernatant was centrifuged at 100 000 g for 60 min ; the resulting high-speed supernatant was designated the ' cytosol ' and the high-speed pellet was designated the ' nonnuclear membrane ' fraction, consisting of endoplasmic reticulum, plasma membrane and other organelles. It should be noted that in this protocol, any unbroken cells would contaminate the nuclear fraction and any membrane from disrupted nuclei would contaminate the non-nuclear membrane fraction. COX-1 was utilized as a marker protein distributed in the endoplasmic reticulum and nuclear envelope, and ICAM-1 was utilized as a plasma membrane marker. Isolated nuclei were disrupted by sonication (10 bursts at 20 % duty cycle) with a Branson sonicator, and soluble and pelletable fractions separated by ultracentrifugation as described above. Aliquots of subcellular fractions were sonicated (10 bursts at 20 % duty cycle) and protein concentrations were determined by a modified Coomassie dye-binding assay (Pierce Chemical), using BSA as standard. Samples containing 10 µg of protein were separated by 7.5 % SDS\PAGE under reducing (for cPLA # and COX-1) or nonreducing (for ICAM-1) conditions and transferred to nitrocellulose membranes for immunoblot analysis as described previously [21] . Membranes were washed and probed with antibodies against cPLA # (1 : 1000 titre), COX-1 (1 : 200 titre), and ICAM-1 (1 : 1000 titre), washed, and then incubated with an appropriate horseradish peroxidase-conjugated secondary antibody (1 : 5000). Bands were visualized using the ECL chemiluminescence system (Amersham). Multiple exposure times were taken for all blots to ensure that band densities were within the linear range of exposure.
Analysis of phospholipid hydrolysis
To determine the membrane site(s) at which phospholipids were hydrolysed in response to agonist stimulation, 10( prelabelled AECs were washed and incubated for 60 min in DMEM containing 0.1 % BSA in the presence or absence of 5 µM A23187. Total release of [$H]AA in each plate was determined by scintillation counting of an aliquot of medium. Cells were trypsinized, after which the trypsin was neutralized by the addition of 5 ml of DMEM plus 10 % (v\v) fetal-calf serum. Cells were pelleted, disrupted, and separated into subcellular fractions as described above. Lipids in both the nuclear and nonnuclear membrane fractions were extracted in chloroform\ methanol (2 : 1, v\v) as previously described [19] , evaporated to dryness under N # , and stored under N # at k20 mC. Neutral lipids were separated by TLC [19] , and radioactivity in the spot corresponding to phospholipids was quantified by scintillation counting.
RESULTS

Effect of chelation of intracellular Ca 2 + on deacylation in response to A23187
In order to determine whether deacylation induced by A23187 was dependent on intracellular Ca# + , cells were preloaded for 60 min with the intracellular Ca# + chelator, BAPTA, prior to stimulation. The effects of BAPTA on basal and agoniststimulated AA release are shown in Figure 1 . Since constitutive deacylation of AA is due to the actions of a Ca# + -independent PLA # [22] , it is not surprising that basal AA release was uninhibited by BAPTA. In fact, BAPTA pretreatment itself elicited a rise in basal AA release ; this has been reported previously in endothelial cells [23] . Nevertheless, BAPTA dosedependently inhibited the incremental net release elicited by ionophore. For example, the control level of net agoniststimulated [$H]AA release ( " 14.9 % of incorporated radioactivity) was reduced to " 3.7 % and " 2.3 % by pretreatment with 200 µM and 500 µM BAPTA, respectively. Ionophorestimulated AA release could also be inhibited by carrying out incubations in medium containing the Ca# + chelator EGTA (net A23187-induced [$H]AA release without EGTA, 11.2 % of incorporated radioactivity ; net A23187-induced release with 3 mM EGTA, 1.3 %). Finally, the combination of pretreatment with 200 µM BAPTA plus stimulation in medium containing 3 mM EGTA completely eliminated the increment in AA release attributable to ionophore. Taken together, these results strongly suggest that AA release stimulated by A23187 in AECs is indeed Ca# + -dependent, and that this increment in Ca# + most likely results from an influx of extracellular cation, as has been demonstrated in other cell types [24] .
sn-2 Fatty acid preference for phospholipid hydrolysis in response to A23187
A characteristic of cPLA # is its preference for hydrolysing phospholipids containing AA over other fatty acids in the sn-2
Figure 3 Indirect immunofluorescence microscopic analysis of cPLA 2 localization in AECs
AECs were cultured on glass coverslips and at culture day 7, were incubated for 30 min with DMEM alone (A, B) or DMEM containing 5 µM A23187 (C). Cells were washed, fixed, permeabilized, and stained with either non-immune rabbit IgG (A) or rabbit anti-cPLA 2 IgG (B, C), prior to incubation with a rhodamine-conjugated secondary antibody.
position [25, 26] , which we have also verified to be true for the AEC enzyme [16] . As another approach to investigating the role of cPLA # in mediating phospholipid hydrolysis stimulated by A23187, we compared the ability of this agonist to release 
Effect of AACOCF 3 on AA release in response to A23187
Among Ca# + -dependent PLA # s, cPLA # is selectively inhibited by the trifluoromethyl ketone derivative of AA in cell-free systems [27] , and its inhibition by this agent has previously been demonstrated in intact cells as well [20, 28] . The effects of AACOCF $ on AA deacylation stimulated by A23187 were therefore examined. This drug binds avidly to albumin. As an alternate means to minimizing the possible contributions of both re-acylation and metabolism, cells were therefore pretreated with 10 µM ETYA prior to addition of the inhibitor and, subsequently, the agonist. As shown in Figure 2 , AACOCF $ dose-dependently inhibited AA deacylation in response to A23187 over the same concentration range reported to inhibit AA release and metabolism in other cell types [28] ; peak inhibition of " 80 % occurred at 75 µM. These results provide further support for the involvement of cPLA # in mediating ionophore-induced AA release.
Effects of A23187 on translocation of cPLA 2 in rat AECs : immunofluorescence microscopy
We utilized indirect immunofluorescence microscopy with a rabbit anti-cPLA # antibody to examine the intracellular distribution of cPLA # in resting and stimulated rat AECs. Monolayers of resting cells incubated for 30 min with medium alone showed diffuse fluorescence across the entire cell ( Figure 3B ). That this staining specifically represented cPLA # was demonstrated by the negative staining obtained with normal nonimmune rabbit IgG ( Figure 3A ). Cells incubated with 5 µM A23187 for 30 min ( Figure 3C ) exhibited a dramatic change in their staining pattern from that seen in resting cells. The diffuse staining across the entire cell was diminished, and a concentration of fluorescence was instead observed at the nucleus, particularly in a rim around the nuclear margin. This shift in immunofluorescence pattern in AECs was dependent on the concentration of A23187 added, as doses less than 1-2 µM caused no or little change, and 3 µM caused an intermediate degree of redistribution (not shown) ; these results correspond to the dose-dependency of ionophore-induced AA release [15] in these cells. A similar pattern of fluorescence around the nuclear margin was observed when AECs were stimulated with the protein kinase C activator phorbol myristate acetate (results not shown).
Effects of A23187 on translocation of cPLA 2 in rat AECs : immunoblot analysis
To complement the immunofluorescence microscopy data presented above, translocation of cPLA # was also assessed by immunoblot analysis of subcellular fractions obtained from unstimulated and A23187-stimulatated AECs. As shown in Figure 4 , cPLA # was distributed almost exclusively in the cytosolic fraction of unstimulated cells. Upon ionophore activation, there was a loss of cPLA # protein from the cytosol and a corresponding increase of this band in the nuclear pelletable fraction, consistent with redistribution to the nuclear envelope. Importantly, no discernible increase was detected in the nonnuclear membrane fraction of activated cells. Distribution of ICAM-1 was also examined in the subcellular fractions ; as an exclusive plasma membrane marker, its abundance in the nuclear pellet provides an indication of the extent to which the nuclear fraction was contaminated with unbroken intact cells. As demonstrated in Figure 4 , a very low level of ICAM-1 in the nuclear pellet indicates a very low level of contamination with intact cells. Given the relative abundance of both ICAM-1 and COX-1 in the non-nuclear membrane fraction, an appreciable cPLA # band would also be expected in this fraction if the cPLA # in the Figure 4 Immunoblot analysis of cPLA 2 
and marker proteins in subcellular fractions of AECs
AECs in suspension were incubated for 30 min in the absence or presence of 5 µM A23187, then washed, disrupted, and fractionated. Aliquots of subcellular fractions (C, cytosol ; M, nonnuclear membrane ; S, nuclear soluble ; P, nuclear pelletable) containing 10 µg of protein were subjected to immunoblot analysis for cPLA 2 , COX-1 and ICAM-1. Blots are representative of three independent experiments.
nuclear pelletable fraction of activated cells represented contamination from either plasma membrane or endoplasmic reticulum. The finding that cPLA # protein was redistributed exclusively to the nuclear pellet is consistent with the immunofluorescence data suggesting that translocation of this enzyme is targeted primarily to the nuclear envelope.
Intracellular site of phospholipid hydrolysis in AECs stimulated with A23187
It is assumed that translocation of cPLA # to a membrane site is required in order for the enzyme to gain access to its phospholipid substrates. However, it remains to be established whether hydrolysis of AA from nuclear membrane phospholipids occurs subsequent to cPLA # translocation to the nuclear envelope. We therefore prelabelled AECs for 24 h with [$H]AA, incubated them with or without A23187 in the presence of BSA, and examined the loss of radioactivity from phospholipids extracted separately from nuclear and non-nuclear membranes. In three independent experiments, 63.7p2.6 % (meanpS.E.M.) of the total [$H]AA d.p.m. incorporated into cellular phospholipids of unstimulated control cells was distributed in the nuclear membrane phospholipids. As shown in Table 1 , all of the increase in Table 1 Contribution of nuclear membrane phospholipids to AA hydrolysis in response to A23187 Prelabelled AECs (10 7 cells) were incubated for 60 min with DMEM containing 0.1 % BSA in the presence or absence of A23187. [ 3 H]AA release into the medium was determined, and the cells were then trypsinized, disrupted by dounce homogenization, and nuclei and non-nuclear membranes obtained by differential centrifugation. Extracted lipids from both of these compartments were subjected to TLC in order to separate phospholipids, and the radioactivity in the phospholipid spots quantified. Differences in d.p.m. between ionophore-stimulated and unstimulated dishes are presented as positive values for AA release into the medium, and as negative values for nuclear, non-nuclear, and total (nuclear plus non-nuclear) phospholipids. Each value represents the meanpS.E.M. from three independent experiments. Figures 3 and 4 , is associated with deacylation of AA primarily from nuclear membrane phospholipids.
DISCUSSION
A hallmark of cPLA # activation is thought to be its ability to undergo Ca# + -dependent translocation from the cytosol to intracellular membranes [12, 26] . It is assumed that this translocation event serves to bring the enzyme in proximity to its phospholipid substrates. Previous studies with peritoneal macrophages [14] and rat basophilic leukaemia cells [13] have led to the surprising conclusion that it is the nuclear envelope, rather than the plasma membrane or endoplasmic reticulum, that is the target for redistribution of cPLA # in activated cells. However, it has not previously been established that the translocation of cPLA # protein results in the enzymic function of cPLA # , namely, phospholipid hydrolysis, at this intracellular site. In this study, we have utilized an experimental system (ionophore A23187 stimulation of rat AECs) in which cPLA # was shown to mediate deacylation of AA. Using both indirect immunofluorescence microscopy and subcellular fractionation with immunoblot analysis, we have confirmed, for the first time in a non-bonemarrow-derived cell type, that cPLA # protein translocates to the nuclear envelope upon cell activation. Most importantly, using subcellular fractionation techniques, we have demonstrated for the first time in any cell type that phospholipid hydrolysis which occurs following agonist stimulation is localized predominantly to the nuclear membrane. These results therefore provide the functional information, previously lacking, which links the enzymic action of cPLA # with its presence at the nuclear envelope in intact cells.
We have previously demonstrated that rat AECs contain cPLA # [16] . Moreover, we showed that expression and activity of cPLA # increase as these cells are cultured for 7 days following isolation [18] , with corresponding increases in ionophore-stimulated AA release [19] . In fact, Ca# + -dependent PLA # activity in lysates of day 7 AECs was largely abolished by incubation of lysates with a neutralizing monoclonal antibody against cPLA # [19] . We chose to carry out the present experiments in day 7
